BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,966,759 | -22.2% | 555,558 | -6.1% | 0.02% | -22.2% |
| Q2 2023 | $26,947,965 | -27.7% | 591,483 | -35.6% | 0.03% | -28.9% |
| Q1 2023 | $37,268,192 | -12.6% | 918,841 | +9.8% | 0.04% | -15.6% |
| Q4 2022 | $42,639,107 | +0.9% | 836,553 | +6.7% | 0.04% | -4.3% |
| Q3 2022 | $42,238,000 | -30.3% | 784,223 | -16.9% | 0.05% | -25.4% |
| Q2 2022 | $60,584,000 | -7.3% | 943,236 | +11.8% | 0.06% | +12.5% |
| Q1 2022 | $65,389,000 | -7.3% | 843,305 | +2.6% | 0.06% | +51.4% |
| Q4 2021 | $70,548,000 | +3.5% | 821,852 | -3.0% | 0.04% | -2.6% |
| Q3 2021 | $68,151,000 | +2.3% | 847,332 | +4.1% | 0.04% | +8.6% |
| Q2 2021 | $66,617,000 | -1.3% | 813,788 | +1.7% | 0.04% | +2.9% |
| Q1 2021 | $67,489,000 | +0.3% | 800,208 | -4.5% | 0.03% | +3.0% |
| Q4 2020 | $67,259,000 | -22.6% | 838,210 | -22.4% | 0.03% | -37.7% |
| Q3 2020 | $86,889,000 | -5.5% | 1,080,422 | +1.2% | 0.05% | -19.7% |
| Q2 2020 | $91,925,000 | +18.2% | 1,067,654 | +11.5% | 0.07% | -1.5% |
| Q1 2020 | $77,768,000 | -40.8% | 957,865 | -39.0% | 0.07% | -30.2% |
| Q4 2019 | $131,291,000 | +27.6% | 1,570,093 | +33.4% | 0.10% | +10.3% |
| Q3 2019 | $102,932,000 | +22.2% | 1,176,763 | +14.4% | 0.09% | +16.0% |
| Q2 2019 | $84,210,000 | +4.6% | 1,028,206 | +3.8% | 0.08% | +2.7% |
| Q1 2019 | $80,541,000 | +47.1% | 990,540 | +19.1% | 0.07% | +28.1% |
| Q4 2018 | $54,751,000 | -15.2% | 831,812 | -0.6% | 0.06% | -1.7% |
| Q3 2018 | $64,532,000 | -10.5% | 837,087 | -14.3% | 0.06% | -17.1% |
| Q2 2018 | $72,085,000 | +9.8% | 976,247 | -3.3% | 0.07% | +14.8% |
| Q1 2018 | $65,679,000 | -10.1% | 1,009,809 | -10.7% | 0.06% | -6.2% |
| Q4 2017 | $73,092,000 | +3.1% | 1,130,767 | +0.1% | 0.06% | -5.8% |
| Q3 2017 | $70,913,000 | +7.0% | 1,130,108 | +3.2% | 0.07% | +6.2% |
| Q2 2017 | $66,268,000 | +6.8% | 1,094,619 | -8.5% | 0.06% | +16.1% |
| Q1 2017 | $62,072,000 | +29.0% | 1,196,883 | +10.3% | 0.06% | +16.7% |
| Q4 2016 | $48,123,000 | -23.5% | 1,085,303 | -17.8% | 0.05% | -20.0% |
| Q3 2016 | $62,883,000 | +17.1% | 1,321,069 | +11.2% | 0.06% | 0.0% |
| Q2 2016 | $53,716,000 | +11.3% | 1,187,902 | +1.1% | 0.06% | +3.4% |
| Q1 2016 | $48,274,000 | -3.7% | 1,175,134 | -10.6% | 0.06% | 0.0% |
| Q4 2015 | $50,127,000 | +24.1% | 1,313,961 | +6.9% | 0.06% | +20.8% |
| Q3 2015 | $40,393,000 | -85.8% | 1,229,665 | -69.8% | 0.05% | -82.7% |
| Q2 2015 | $285,053,000 | +209.4% | 4,076,241 | +203.1% | 0.28% | +198.9% |
| Q1 2015 | $92,135,000 | -8.8% | 1,345,045 | -2.4% | 0.09% | +3.3% |
| Q4 2014 | $101,041,000 | -3.2% | 1,378,660 | -5.2% | 0.09% | +5.9% |
| Q3 2014 | $104,400,000 | +0.8% | 1,454,659 | +1.5% | 0.08% | 0.0% |
| Q2 2014 | $103,603,000 | +17.4% | 1,432,979 | +19.5% | 0.08% | -1.2% |
| Q1 2014 | $88,260,000 | +6.7% | 1,199,525 | +0.8% | 0.09% | +14.7% |
| Q4 2013 | $82,727,000 | +10.0% | 1,189,438 | +3.9% | 0.08% | 0.0% |
| Q3 2013 | $75,183,000 | -22.1% | 1,144,550 | -17.8% | 0.08% | -22.7% |
| Q2 2013 | $96,453,000 | -10.7% | 1,392,413 | -6.4% | 0.10% | -11.0% |
| Q1 2013 | $108,063,000 | – | 1,487,631 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |